Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of PACS Group Inc (NYSE: PACS) closed at $42.68 in the last session, down -0.58% from day before closing price of $42.93. In other words, the price has decreased by -$0.58 from its previous closing price. On the day, 0.74 million shares were traded. PACS stock price reached its highest trading level at $42.92 during the session, while it also had its lowest trading level at $42.02.
Ratios:
We take a closer look at PACS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.71 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 4.74 whereas as Long-Term Debt/Eq ratio is at 4.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 09, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On June 28, 2024, Macquarie started tracking the stock assigning a Outperform rating and target price of $35.Macquarie initiated its Outperform rating on June 28, 2024, with a $35 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 09 ’24 when Hancock Mark sold 8,128,352 shares for $36.25 per share. The transaction valued at 294,652,760 led to the insider holds 45,126,199 shares of the business.
Murray Jason Hulse sold 8,128,352 shares of PACS for $294,652,760 on Sep 09 ’24. The Co-Founder, CEO & Chairman now owns 45,126,199 shares after completing the transaction at $36.25 per share. On Apr 11 ’24, another insider, Millard Jacqueline, who serves as the Director of the company, bought 433 shares for $23.08 each. As a result, the insider paid 9,993 and bolstered with 433 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACS now has a Market Capitalization of 6661750272 and an Enterprise Value of 9151137792. Its current Enterprise Value per Revenue stands at 2.571 whereas that against EBITDA is 36.754.
Stock Price History:
Over the past 52 weeks, PACS has reached a high of $43.23, while it has fallen to a 52-week low of $22.61. The 50-Day Moving Average of the stock is 6.39%, while the 200-Day Moving Average is calculated to be 27.43%.
Shares Statistics:
According to the various share statistics, PACS traded on average about 714.86K shares per day over the past 3-months and 670980 shares per day over the past 10 days. A total of 155.18M shares are outstanding, with a floating share count of 37.97M. Insiders hold about 75.53% of the company’s shares, while institutions hold 19.63% stake in the company. Shares short for PACS as of 1728950400 were 2900588 with a Short Ratio of 4.06, compared to 1726185600 on 2888874.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0145585835
